MML Investors Services
MDGL icon

MML Investors Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

MML Investors Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787K Buy
1,466
+48
+3% +$24.6K ﹤0.01% 2162
2026
Q1 		$742K Sell
1,418
-250
-15% -$119K ﹤0.01% 1965
2025
Q4 		$971K Buy
1,668
+278
+20% +$142K ﹤0.01% 1815
2025
Q3 		$638K Sell
1,390
-121
-8% -$45.1K ﹤0.01% 2013
2025
Q2 		$457K Buy
1,511
+2
+0.1% +$596 ﹤0.01% 2157
2025
Q1 		$500K Buy
1,509
+25
+2% +$8.21K ﹤0.01% 1988
2024
Q4 		$458K Buy
1,484
+229
+18% +$64.4K ﹤0.01% 1966
2024
Q3 		$266K Buy
1,255
+10
+0.8% +$2.56K ﹤0.01% 2260
2024
Q2 		$349K Buy
1,245
+184
+17% +$43.8K ﹤0.01% 1995
2024
Q1 		$283K Buy
1,061
+34
+3% +$8.01K ﹤0.01% 2145
2023
Q4 		$238K Buy
+1,027
New +$180K ﹤0.01% 2201
2022
Q1 		– Sell
-5,691
Closed -$482K – 2106
2021
Q4 		$482K Buy
+5,691
New +$468K ﹤0.01% 1434

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MML Investors Services's MDGL Position: Q2 2026 in Review

MML Investors Services increased its Madrigal Pharmaceuticals (MDGL) stake by 3.4% in Q2 2026, buying an estimated $24.6K and bringing the position to 1,466 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #2162.

MML Investors Services first reported a position in MDGL in Q4 2021 and has held it in 12 quarters since. The position peaked at $971K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • MML Investors Services held 1,466 shares of Madrigal Pharmaceuticals worth $787K as of Q2 2026.
  • MML Investors Services bought 48 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $24.6K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2162 holding.
  • MML Investors Services first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
  • MML Investors Services's Madrigal Pharmaceuticals position peaked at $971K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.